847.17澳幣5.05(0.6%)
2024/07/26更新
績效 / 1月10.38%
3月21.06%
1年25.24%
晨星評等-
- 1.現金1.16%
- 2.股票7.95%
- 3.債券-0.06%
- 4.其他90.95%
- 1.美國90.95%
- 2.英國2.09%
- 3.歐元區2.04%
- 4.歐洲不包含歐元區1.99%
- 5.加拿大1.83%
- 1.Regeneron Pharmaceuticals Inc5.33%
- 2.argenx SE ADR4.55%
- 3.Sarepta Therapeutics Inc4.26%
- 4.Alnylam Pharmaceuticals Inc4.17%
- 5.Biomarin Pharmaceutical Inc4.10%
- 6.Vertex Pharmaceuticals Inc3.48%
- 7.Blueprint Medicines Corp3.30%
- 8.Neurocrine Biosciences Inc3.26%
- 9.Insmed Inc3.13%
- 10.Amgen Inc3.08%
- 1.現金1.16%
- 2.股票7.95%
- 3.債券-0.06%
- 4.其他90.95%
- 1.美國90.95%
- 2.英國2.09%
- 3.歐元區2.04%
- 4.歐洲不包含歐元區1.99%
- 5.加拿大1.83%
- 1.Regeneron Pharmaceuticals Inc5.33%
- 2.argenx SE ADR4.55%
- 3.Sarepta Therapeutics Inc4.26%
- 4.Alnylam Pharmaceuticals Inc4.17%
- 5.Biomarin Pharmaceutical Inc4.10%
- 6.Vertex Pharmaceuticals Inc3.48%
- 7.Blueprint Medicines Corp3.30%
- 8.Neurocrine Biosciences Inc3.26%
- 9.Insmed Inc3.13%
- 10.Amgen Inc3.08%